Incorporated in 1976 and based in Waltham, MA, Nova Biomedical is a world leader in the development and manufacturing of state-of-the-art, whole blood, point-of-care and critical care analyzers, as well as providing the biotechnology industry with the most advanced instruments for cell culture monitoring. Nova is one of the fastest growing in vitro diagnostic companies in the world. Nova’s biosensor technology is incorporated in products ranging from handheld meters for glucose self- and point-of-care testing to critical care whole blood analyzers designed for rapid measurement of over 20 analytes. Nova employs over 1,100 people worldwide and has wholly owned subsidiaries located in Brazil, Canada, France, Germany, Great Britain, Italy, Japan, and Taiwan. Certified by the International Organization for Standardization, Nova has manufacturing operations located in the U.S., Taiwan, and Brazil.
Nova has sales and service operations in 100 countries through Nova subsidiaries or distributors. Nova’s wholly-owned subsidiaries are located in Brazil, Canada, France, Germany, the U.K., Japan, and the U.S., with distributors in 92 additional countries. Nova subsidiaries and distributors provide product information, demonstrations, local product inventory, and complete technical support. Whether you are located in North America, Europe, Russia, Eastern Europe, the Middle East, Africa, Asia, the Pacific Islands, Latin America, or the Indian Subcontinent, Nova can support your point-of-care and critical care testing needs. Nova’s global manufacturing operations take place in four facilities certified by the International Organization for Standardization (ISO) and are located in Waltham and Billerica, Massachusetts, USA; Taipei, Taiwan; and Belo Horizonte, Brazil. These facilities occupy a total of 42,000 square meters (420,000 square feet) of manufacturing space.